SCHEMBL6426799

SCHEMBL6426799

CCCC[Si](CCCC)(CCCC)OS(=O)(=O)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.36
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
FAAH O00519 5/20 0.30
CES1 P23141 5/20 0.30
CES2 O00748 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5154385 0.88 EPHX1 (0.31) EPHX1
SCHEMBL425715 0.82 EPHX1 (0.35) EPHX1NR1H2NR1H3
SCHEMBL28407153 0.82 EPHX1 (0.35) EPHX1NR1H2NR1H3
SCHEMBL28408541 0.80
SCHEMBL36993 0.79 CA1 (0.30)
SCHEMBL12418037 0.78 EPHX1 (0.33) EPHX1CES1
SCHEMBL9586160 0.77 EPHX1 (0.32) EPHX1
SCHEMBL6883108 0.76 CA1 (0.34) FAAH
SCHEMBL424481 0.76 EPHX1 (0.41) EPHX1FAAHCES1CES2
SCHEMBL423499 0.76 EPHX1 (0.41) EPHX1FAAHCES1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778615-B1 SILYL PHOSPHINE COMPOUND, METHOD FOR PRODUCING SILYL PHOSPHINE COMPOUND AND METHOD FOR FORMING INP QUANTUM DOT NIPPON CHEMICAL IND (JP) 2024-08-07 EP claimed
US-11578266-B2 Silyl phosphine compound, process for producing silyl phosphine compound and process for producing InP quantum dots NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2023-02-14 US claimed
CN-109715643-B Process for producing silylphosphine compound and silylphosphine compound 日本化学工业株式会社 2022-06-28 CN claimed
EP-3778615-A1 SILYL PHOSPHINE COMPOUND, METHOD FOR PRODUCING SILYL PHOSPHINE COMPOUND AND METHOD FOR FORMING INP QUANTUM DOT Nippon Chemical Industrial Co., Ltd. (JP) 2021-02-17 EP claimed
US-20210002548-A1 SILYL PHOSPHINE COMPOUND, PROCESS FOR PRODUCING SILYL PHOSPHINE COMPOUND AND PROCESS FOR PRODUCING InP QUANTUM DOTS NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2021-01-07 US claimed
CN-111868066-A Silylphosphine compound, method for producing silylphosphine compound, and method for producing InP quantum dot 日本化学工业株式会社 2020-10-30 CN claimed
EP-3521296-B1 SILYL PHOSPHINE COMPOUND MANUFACTURING METHOD AND SILYL PHOSPHINE COMPOUND NIPPON CHEMICAL IND (JP) 2020-10-28 EP claimed
CN-106715448-B Process for preparing tris (trialkylsilyl) phosphine SK化学公司 2020-03-03 CN claimed
WO-2019188680-A1 SILYL PHOSPHINE COMPOUND, METHOD FOR PRODUCING SILYL PHOSPHINE COMPOUND AND METHOD FOR FORMING InP QUANTUM DOT 日本化学工業株式会社 2019-10-03 WO claimed
US-20190263845-A1 PROCESS FOR PRODUCING SILYL PHOSPHINE COMPOUND AND SILYL PHOSPHINE COMPOUND NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2019-08-29 US claimed
EP-3222623-B1 METHOD FOR PREPARING TRIS(TRIALKYLSILYL)PHOSPHINE SK CHEMICALS CO LTD (KR) 2019-08-28 EP claimed
EP-3521296-A1 SILYL PHOSPHINE COMPOUND MANUFACTURING METHOD AND SILYL PHOSPHINE COMPOUND Nippon Chemical Industrial Co., Ltd. (JP) 2019-08-07 EP claimed
US-10040809-B2 Method for preparing tris(trialkylsilyl)phosphine SK CHEMICALS CO., LTD. (KR) 2018-08-07 US claimed
EP-3222623-A1 METHOD FOR PREPARING TRIS(TRIALKYLSILYL)PHOSPHINE SK Chemicals Co., Ltd. (KR) 2017-09-27 EP claimed
US-20170226138-A1 METHOD FOR PREPARING TRIS(TRIALKYLSILYL)PHOSPHINE SK CHEMICALS CO., LTD. (KR) 2017-08-10 US claimed
EP-3778615-B1 SILYL PHOSPHINE COMPOUND, METHOD FOR PRODUCING SILYL PHOSPHINE COMPOUND AND METHOD FOR FORMING INP QUANTUM DOT NIPPON CHEMICAL IND (JP) 2024-08-07 EP disclosed
US-20230167359-A1 SILYL PHOSPHINE COMPOUND, PROCESS FOR PRODUCING SILYL PHOSPHINE COMPOUND AND PROCESS FOR PRODUCING InP QUANTUM DOTS NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2023-06-01 US disclosed
EP-1413574-A1 PYRROLIDINE DERIVATIVES AND METHOD OF SYNTHESIZING THESE Eizai Co., Ltd. (JP) 2004-04-28 EP disclosed
US-20030055297-A1 An alkyl, cycloalkyl, arylalkyl dihydroxy compound useful as intermediates; a cost-effective preparation ABBOTT LABORATORIES 2003-03-20 US disclosed
WO-2002081441-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRROLIDINE NEURAMINIDASE INHIBITORS ABBOTT LABORATORIES (US) 2002-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578266-B2 Silyl phosphine compound, process for producing silyl phosphine compound and process for producing InP quantum dots INPP5B, INPP5A, INPPL1 EPHX1 3934/4885NR1H2 3074/4885NR1H3 3439/4885
US-20170226138-A1 METHOD FOR PREPARING TRIS(TRIALKYLSILYL)PHOSPHINE INPPL1, TYMP, PHOSPHO1 EPHX1 3544/4885NR1H2 4004/4885NR1H3 3394/4885
US-10040809-B2 Method for preparing tris(trialkylsilyl)phosphine INPPL1, TYMP, PHOSPHO1 EPHX1 3544/4885NR1H2 4004/4885NR1H3 3394/4885
US-20210002548-A1 SILYL PHOSPHINE COMPOUND, PROCESS FOR PRODUCING SILYL PHOSPHINE COMPOUND AND PROCESS FOR PRODUCING InP QUANTUM DOTS INPP5B, INPP5A, INPPL1 EPHX1 3934/4885NR1H2 3074/4885NR1H3 3439/4885
US-20190263845-A1 PROCESS FOR PRODUCING SILYL PHOSPHINE COMPOUND AND SILYL PHOSPHINE COMPOUND SMS, SLK, SRM EPHX1 2193/4885NR1H2 3120/4885NR1H3 3009/4885
US-20030055297-A1 An alkyl, cycloalkyl, arylalkyl dihydroxy compound useful as intermediates; a cost-effective preparation NEU4, NEU2, NEU1 EPHX1 968/4885NR1H2 467/4885NR1H3 393/4885
US-20230167359-A1 SILYL PHOSPHINE COMPOUND, PROCESS FOR PRODUCING SILYL PHOSPHINE COMPOUND AND PROCESS FOR PRODUCING InP QUANTUM DOTS INPP5B, INPP5A, INPPL1 EPHX1 3934/4885NR1H2 3074/4885NR1H3 3439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.